These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
653 related articles for article (PubMed ID: 3707090)
21. Lasting changes in high affinity 3H-spiperone binding to the rat striatum and mesolimbic area after chronic methamphetamine administration: evaluation of dopaminergic and serotonergic receptor components. Akiyama K; Sato M; Kashihara K; Otsuki S Biol Psychiatry; 1982 Dec; 17(12):1389-402. PubMed ID: 7159638 [TBL] [Abstract][Full Text] [Related]
22. Denervation supersensitivity of striatal D2 dopamine receptors is restricted to the ventro- and dorsolateral regions of the striatum. Savasta M; Dubois A; Feuerstein C; Manier M; Scatton B Neurosci Lett; 1987 Feb; 74(2):180-6. PubMed ID: 2883609 [TBL] [Abstract][Full Text] [Related]
23. Striatal D1- and D2-dopamine receptor sites are separately detectable in vivo. Leslie CA; Bennett JP Brain Res; 1987 Jul; 415(1):90-7. PubMed ID: 2957025 [TBL] [Abstract][Full Text] [Related]
24. Striatal dopamine depletion, dopamine receptor stimulation, and GABA metabolism: implications for the therapy of Parkinson's disease. Bennett JP Ann Neurol; 1986 Feb; 19(2):194-7. PubMed ID: 3083762 [TBL] [Abstract][Full Text] [Related]
25. [3H]spiperone binds selectively to rat striatal D2 dopamine receptors in vivo: a kinetic and pharmacological analysis. Leslie CA; Bennett JP Brain Res; 1987 Mar; 407(2):253-62. PubMed ID: 2952221 [TBL] [Abstract][Full Text] [Related]
26. Quantification of in vivo spiperone binding in the rat striatum after lesions produced by kainate or decortication. Van der Werf JF; Van het Schip F; Sebens JB; Korf J Eur J Pharmacol; 1984 Jul; 102(3-4):387-99. PubMed ID: 6436037 [TBL] [Abstract][Full Text] [Related]
27. Turnover of specific [3H]spiperone and [3H]N,n-propylnorapomorphine binding sites in rat striatum following phenoxybenzamine administration. Hall MD; Jenner P; Marsden CD Biochem Pharmacol; 1983 Oct; 32(19):2973-7. PubMed ID: 6626267 [TBL] [Abstract][Full Text] [Related]
28. Aging brain and dopamine receptors: abnormal regulation by CCK-8 of 3H-spiperone labeled dopamine receptors in striatal membranes. Agnati LF; Fuxe K; Battistini N; Benfenati F Acta Physiol Scand; 1984 Mar; 120(3):465-7. PubMed ID: 6331074 [No Abstract] [Full Text] [Related]
29. Selective labelling of dopamine (D2) receptors in rat striatum by [3H]domperidone but not by [3H]spiperone. Lazareno S; Nahorski SR Eur J Pharmacol; 1982 Jul; 81(2):273-85. PubMed ID: 7117377 [TBL] [Abstract][Full Text] [Related]
30. Cortical ablation fails to influence striatal dopamine target cell supersensitivity induced by nigrostriatal denervation in the rat. Paturle L; Fage D; Fourrier O; Vernier P; Feuerstein C; Demenge P; Scatton B Brain Res; 1987 Feb; 402(2):383-6. PubMed ID: 3828803 [TBL] [Abstract][Full Text] [Related]
31. Chronic proglumide increases [3H]spiperone binding in the rat brain. Bean AJ; Baldy WJ; Martin GE Eur J Pharmacol; 1985 Oct; 117(1):97-101. PubMed ID: 4085545 [TBL] [Abstract][Full Text] [Related]
32. Optimal conditions for [3H]apomorphine binding and anomalous equilibrium binding of [3H]apomorphine and [3H]spiperone to rat striatal membranes: involvement of surface phenomena versus multiple binding sites. Leysen JE; Gommeren W J Neurochem; 1981 Jan; 36(1):201-19. PubMed ID: 7463046 [TBL] [Abstract][Full Text] [Related]
34. Autoradiographic identification of D1 dopamine receptors labelled with [3H]dopamine: distribution, regulation and relationship to coupling. Hervé D; Trovero F; Blanc G; Glowinski J; Tassin JP Neuroscience; 1992; 46(3):687-700. PubMed ID: 1532052 [TBL] [Abstract][Full Text] [Related]
35. Distinct binding patterns of [3H]raclopride and [3H]spiperone at dopamine D2 receptors in vivo in rat brain. Implications for pet studies. Bischoff S; Gunst F J Recept Signal Transduct Res; 1997; 17(1-3):419-31. PubMed ID: 9029505 [TBL] [Abstract][Full Text] [Related]
36. Analysis of [3H]spiperone binding sites in the rat striatum and frontoparietal cortex by means of quantitative receptor autoradiography after inactivation of dopamine receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo: selective protection by sulpiride in the striatum. Fuxe K; Meller E; Goldstein M; Benfenati F; Agnati LF Neurosci Lett; 1986 Feb; 64(2):163-8. PubMed ID: 3960398 [TBL] [Abstract][Full Text] [Related]
37. Analysis of dopamine interactions with [3H]-spiperone binding sites on rat corpus striatum membranes [proceedings]. Howlett DR; Nahorski SR Br J Pharmacol; 1979 Jul; 66(3):468P-469P. PubMed ID: 526752 [No Abstract] [Full Text] [Related]
38. Dopamine D2 receptor dissociation constant for spiperone: identical values using 3H-labeled agonist or 3H-labeled antagonist. Seeman P; Grigoriadis D Biochem Pharmacol; 1985 Nov; 34(22):4065-6. PubMed ID: 4062976 [No Abstract] [Full Text] [Related]
39. 77Br-p-bromospiperone: a ligand for in vivo labelling of dopamine receptors. Owen F; Poulter M; Mashal RD; Crow TJ; Veall N; Zanelli GD Life Sci; 1983 Aug; 33(8):765-8. PubMed ID: 6888192 [TBL] [Abstract][Full Text] [Related]
40. Dopamine receptor binding of a novel dibenzodioxazocine derivative, EGYT-2509. Gyüre K; Szentendrei T; Kanyicska B; Fekete MI; Rónai AZ Pol J Pharmacol Pharm; 1985; 37(3):253-61. PubMed ID: 2866498 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]